Antimotility agents for chronic diarrhoea in people with HIV/AIDS

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2008, Pages

  Nwachukwu, Chukwuemeka E ^a   Okebe, Joseph U ^b  

^a UNIVERSITY OF CALABAR   (Nigeria)

^b MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

Author keywords

[No Author keywords available]

Indexed keywords

ATTAPULGITE; CODEINE; DIPHENOXYLATE; LOPERAMIDE; PLACEBO;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CHRONIC DIARRHEA; CLINICAL TRIAL; DEHYDRATION; DRUG EFFICACY; DRUG FATALITY; FECES ANALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; REVIEW; SYSTEMATIC REVIEW;

EID: 55049130199     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD005644.pub2     Document Type: Review

References (48)

1. Ilboudo 1997 {publisheddata only} * Ilboudo D, Kadio A, Monny L, Mpele P, Ndri-Yoman T, Vohito MD. Therapeutic effect of mormoiron attapulgite in diarrhoea with AIDS [Effet therapeutique de l'attapulgite demormoiron active dans la diarrhee liee au syndrome d'immuno-deficience acquise (SIDA)]. Medecine d'Afrique Noire 1997;44(5):307-12.
2. Compean 1994 {publisheddata only} Compean DG, Jimenez JR, De La Garza FG, Saenz C, Maldonado H, Barragan RF, et al.Octreotide therapy of large-refractory AIDS-associated diarrhea: a randomised controlled trial. AIDS 1994;8:1563-7.
3. Abubakar 2007 Abubakar I, Aliyu SH, Arumugam C, Hunter PR, Usman NK. Prevention and treatment of cryptosporidiosis in immunocompromised patients. CochraneDatabase of Systematic Reviews 2007, Issue 1. [Art. No.: CD004932. DOI: 10.1002/14651858.CD004932]
4. Adelman 1996 Adelman RD, Solhang MJ. Fluid therapy. In: Nelson WD, Behrman RE, Kliegman RM, Arvin AM editor(s). Nelson Textbook of Paediatrics. 15. Philadelphia: W. B. Saunders, 1996.
5. Anastasi 2000 Anastasi JK, Capili B. HIV and diarrhea in the era of HAART: 1998 New York state hospitalisations. American Journal of Infections Control 2000;28:262-6.
6. Anastasi 2003 Anastasi JK, McMahon DJ. Testing strategies to reduce diarrhea in persons with HIV using traditional Chinese medicine: acupuncture and moxibustion. The Journal of the Association of Nurses in AIDS Care 2003;14(3):28-40.
7. Armon 2001 Armon K, Stephenson T, MacFaul R, Eccleston P, Werneke U. An evidence and concensus based guideline for acute diarrhoea management. Archives of Diseases in Childhood 2001;85:132-42.
8. Brawner-Caluag 1993 Brawner-Caluag J. Mendoza RM, Valencia CI, Galang RM. A phase IV study of Loperamide hydrochloride in acute non-dysenteric diarrhea among hospitalized adult Filipino patients. Philipines Journal of Internal Medicine 1993;31:273-84.
9. Carcamo 2005 Carcamo C, Hooton T, Wener MH, Weiss NS, Gilman R, Arevalo J, et al.Etiologies and manifestations of persistent diarrhoea in adults with HIV-1 infection: a case-control study in Lima, Peru. Journal of Infectious Diseases 2005;191(1):11-9.
10. Carr 2000 Carr A, Cooper DA. Adverse effects of antiretroviral therapy. Lancet 2000;356:1423-30.
11. Cohen 1999 Cohen MR, Mitchel TF, Bacchetti P, Child C, Crawford S, Gaeddert A, et al.Use of a Chinese herbal medicine for treatment of HIV-associated pathogen-negative diarrhea. Integrative Medicine 1999;2:79-84.
12. Deschamps 2000 Deschamps MM, Fitzgerald DW, Pape JE, Johnson WD. HIV Infection in Haiti: natural history and disease progress. AIDS 2000;14:2515-21.
13. Dryden 1988 Dryden MS, Shanson DC. The microbial causes of diarrhoea in patients infected with the human immunodeficiency virus. Journal of Infections 1988;17(2):107-14.
14. Dumitrascu 2004 Dumitrascu DL, Stanculete M, Mitrea I, Dumitrascu DM, Farcas A. The effect of two antidiarrhoeal drugs on the psychosocial adjustment to illness in chronic functional diarrhoea. Romanian Journal of Internal Medicine 2004;42(1):191-7.
15. DuPont 1992 DuPont HL, Cooperstock M, Corrado ML, Fekety R, Murray DM. Evaluation of new anti infective drugs for the treatment of acute infectious diarrhea. Clinical Infectious Diseases 1992;15 Suppl 1:S228-35.
16. DuPont 1993 DuPont HL. Diarrhoeal diseases: current concepts and future challenges. Antimicrobial therapy and prophylaxis. Transactions of the Royal Society of Tropical Medicine and Hygiene 1993;87 Suppl3:31-4.
17. Edwards 1990 Edwards P, Wodak A, Cooper DA, Thompson IL, Penny R. The gastrointestinal manifestations of AIDS. Australian and New Zealand Journal of Medicine 1990;20(2):141-8.
18. Foudraine 1998 Foudraine NA, Weverling GJ, van Gool T, Roos MT, de Wolf F, Koopmans PP, et al.Improvement of chronic diarhoea in patients with advanced HIV-1 infection during potent antiretroviral therapy. AIDS 1998;12(1):35-41.
19. Gassama 2001 Gassama A, Sow PS, Fall F, Camara P, Gueye-N'diaye A, Seng R, et al.Ordinary and opportunistic enteropathogens associated with diarrhea in Senegalese adults in relation to human immunodeficiency virus serostatus. International Journal of Infectious Diseases 2001;5(4):192-8.
20. Greenwood 2004 Greenwood-Van Meerveld B, Gardner CJ, Little PJ, Hicks GA, Dehaven-Hudkins DL. Preclinical studies of opoid antagonists on gastrointestinal function. Neurogastroenterology and Motility 2004;16 Suppl 2:46-53.
21. Guarino 2004 Guarino A, Bruzzese E, DeMarco G, Buccigrossi V. Management of gastrointestinal disorders in children with HIV infection. Paediatric Drugs 2004;6(6):347-62.
22. Guest 2004 Guest JL, Ruffin C, Tschampa JM, DeSilva KE, Rimland D. Differences in rates of diarrhea in patients with human immunodeficiency virus receiving lopinavir-ritonavir or nelfinavir. Pharmacotherapy. 2004;24(6):727-35.
23. Jamjian 2000 Jamjian MC, Mullin S, Ries KM, Spruance SL. Managing the adverse effects of antiretroviral therapy. hivnewsline.com 2000 (assessed 29 september 2005); Vol. 6(4).
24. Kadapu 2002 Kadapu KK, Nagaraja MV, Rao PV, Shasty BA. Azithromycin as treatment for cryptosporidiosis in human immunodeficiency virus disease. Journal of Postgraduate Medicine 2002;48:179-81.
25. Kaplan 2004 Kaplan JE. Diagnosis, Treatment and Prevention of selected common HIV-related opportunistic infections in the Carribean region. Topics in HIV Medicine Dec.2004/Jan 2005;12(5):136-41.
26. Katabira 1999 Katabira ET. Epidemiology and management of diarrheal diseases in HIV-infected persons. International Journal of Infectious Diseases 1999;3:164-7.
27. Krain 2005 Krain A, Fitzgerald DW. HIV antiretroviral therapy in resource-limited settings: experiences from Haiti. Current HIV/AIDS Reports 2005;2(2):98-104.
28. Liu 2005 Liu JP, Manheimer E, Yang M. Herbal medicines for treating HIV infection and AIDS. Cochrane Database of Systematic Reviews 2005, Issue 3.[Art. No.: CD003937. DOI:10.1002/14651858.CD003937.pub2]
29. Logie 2004 Logie DE. Reframing the HIV/AIDS debate in developing countries III: an effective, equitable response. Rural and Remote Health 4 (online) (http://rrh.deakin.edu.au) 2004 (accessed on 16 september 2005).
30. Lutge 2005 Lutge E. The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS. Cochrane Database of Systematic Reviews 2005, Issue 2. [Art. No.: CD005175. DOI:10.1002/14651858. CD005175.pub2]
31. McQuain 2004 McQuain KR. Drugs used in Gatrointestinal Diseases. In: Katzung BG editor(s). Basic & Clinical Pharmacology. 9th Edition. McGraw Hill, 2004:1034-60.
32. Moyle 1998 Moyle GJ, Youle M, Higgs C, Monaghan J, Prince W, Chapman S, et al.Safety, pharmacokinetics and antiretroviral activity of the potent, specific human immunodeficiency virus protease inhibitor nelfinavir: results of a phase I/II trial and extended follow-up in patients infected with human immunodeficiency virus. Journal of Clinical Pharmacology 1998;38:736-43.
33. Mwachari 1998 Mwachari C, Batchelor BI, Paul J, Waiyaki PG, Gilks CF. Chronic diarrhoea among HIV-infected adult patients in Nairobi, Kenya. The Journal of Infection 1998;37(1):48-53.
34. O'Brien 2003 O'Brien ME, Clark RA, Besch CL, Myers L, Kissinger P. Patterns and correlates of discontinuation of the initial HAART regimen in an urban outpatient cohort. Journal of Acquired Immune Deficiency Syndrome 2003;34(4):407-14.
35. O'Dell 1995 O'Dell MW, Lubeck DP, O'Driscoll, Matsuno S. Validity of the Karnofsky Performance Status in an HIV-infected sample. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1995;10(3):350-7.
36. Pape 1994 Pape JW, Verdier RI, Boncy M, Boncy J, Johnson WD. Cyclospora Infection in adults infected with HIV: Clinical manifestations, treatment, and prophylaxis. Annals of Internal Medicine 1994;121:654-7.
37. Schiller 1982 Schiller LR, Davis GR, Santa Ana CA, Morawski SG, Fordtran JS. Studies of mechanism of the antidiarrhoeal effect of codeine. Journal of Clinical Investigations 1982;70(5):999-1008.
38. Schumacher 2004 Schumacher MA, Basbaun AI, Way WL. Opioid Analgesics & Antagonists. In: Katzung BG editor(s). Basic and Clinical Pharmacology. 7th Edition. McGraw Hill, 2004:497-516.
39. Sherman 2000 Sherman DS, Fish DN. Management of protease inhibitor-associated diarrhoea. Clinical Infectious Diseases 2000;30(6):908-14.
40. Silverberg 2004 Silverberg MJ, Gore ME, French AL, Gandhi M, Glesby MJ, Kovacs A, et al.Prevalence of clinical symptoms associated with highly active antiretroviral therapy in the Women's Interangency HIV Study. Clinical Infectious Diseases 2004;39(5):717-24.
41. Turner 2004 Turner MJ, Angel JB, Woodend K, Giguere P. The efficacy of calcium carbonate in the treatment of protease inhibitor-induced persistent diarrhea in HIV-infected patients. HIV Clinical Trials 2004;5(1):19-24.
42. UNAIDS 2004 2004 report on the global AIDS epidemic. Joint United Nations Programme on HIV/AIDS. Geneva, 2004.
43. UNAIDS 2006 UNAIDS. 2006 Report on the Global AIDSEpidemic. 2006:16-43.
44. Walter-Smith 1993 Walter-smith JA. Diarrhoeal diseases: current concepts and future challenges. Malnutrition and infection. Transactions of the Royal Society of Tropical Medicine and Hydiene 1993;87, Suppl 3:13-5.
45. Wang 2005 Wang H, Shieh M, Liao K. A blind, randomised comparison of racecadotril and loperamide for stopping acute diarrhea in adults. World Journal of Gastroenterology 2005;11(10):1540-3.
46. WHO 1991 Guidelines for the clinical management of HIV infections in adults. WHO/GPA. Geneva, 1991.
47. WHO 2005 Interim WHO clinical staging of HIV/AIDS and HIV/AIDS case definitions for surveillance. WHO/HIV/2005.02 2005.
48. WHO 2008 WHO. World Health Statistics. 2008:13-4.